- GlobeNewswire•4 days ago
Expects to Report NSI-189 Phase 2 major depressive disorder study results in Q3 ahead of schedule. GERMANTOWN, Md., March 23, 2017-- Neuralstem, Inc., a biopharmaceutical company focused on the development ...
- GlobeNewswire•10 days ago
GERMANTOWN, Md., March 17, 2017-- Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announces that Rich Daly, ...
- Accesswire•16 days ago
NEW YORK, NY / ACCESSWIRE / March 10, 2017 / U.S. markets rallied late to close up for the day on the 8th anniversary of the S&P 500's bear-market closing low on March 9, 2009. The S&P 500 Index has rallied ...
CUR : Summary for Neuralstem, Inc. - Yahoo Finance
Neuralstem, Inc. (CUR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||5.15 x 2000|
|Ask||6.74 x 3000|
|Day's Range||5.35 - 5.55|
|52 Week Range||0.19 - 6.19|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.09|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|